TYRA
Tyra Biosciences Inc.
$33.59
+$1.12(+3.45%)
45
Overall
60
Value
45
Tech
31
Quality
Market Cap
$815.53M
Volume
564.64K
52W Range
$8.75 - $40.65
Target Price
$50.30
Order:
Income Statement
| Metric | Trend | Chart | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|
| OPERATING EXPENSES | |||||||
| Operating Expenses | $-26.3M | $58.9M | $79.9M | $104.2M | $132.8M | ||
| Research & Development | $20.6M | $43.0M | $62.5M | $80.1M | $102.9M | ||
| Research Expense | $20.6M | $43.0M | $62.5M | $80.1M | $102.9M | ||
| Selling, General & Administrative | $5.7M | $15.9M | $17.4M | $24.1M | $29.8M | ||
| Selling & Marketing Expenses | $-435.0K | $765.0K | -- | -- | -- | ||
| General & Administrative Expenses | $5.7M | $15.9M | $17.4M | $24.1M | $29.8M | ||
| Salaries & Wages | $-2.9M | -- | $13.5M | -- | -- | ||
| Depreciation & Amortization | $-140.0K | $300.0K | $400.0K | $500.0K | -- | ||
| Depreciation & Amortization | $-140.0K | $300.0K | $400.0K | -- | -- | ||
| Amortization | $-5.0K | -- | -- | -- | -- | ||
| Other Operating Expenses | $-331.0K | $-366.0K | $-605.0K | -- | -- | ||
| OPERATING INCOME | |||||||
| Operating income | $-26.3M | $-58.9M | $-79.9M | $-104.2M | $-132.8M | ||
| EBITDA | $-26.2M | $-58.6M | $-68.8M | $-86.0M | $-119.4M | ||
| NON-OPERATING ITEMS | |||||||
| Intinc | $13.0K | -- | $10.8M | $17.7M | $12.8M | ||
| Net Non-Operating Interest Income/Expense | $13.0K | $-3.7M | $10.8M | $17.7M | $12.8M | ||
| Other Income/Expense | $19.0K | $-50.0K | $-384.0K | $-797.0K | -- | ||
| Other Special Charges | $-19.0K | $3.6M | $-39.0K | -- | -- | ||
| PRE-TAX INCOME | |||||||
| EBIT | $-26.3M | $-58.9M | $-69.2M | $-86.5M | $-119.9M | ||
| Pre-Tax Income | $-26.3M | $-55.3M | $-69.1M | $-86.5M | $-119.9M | ||
| INCOME TAX | |||||||
| Tax Provision | $-1.0K | $-58.0K | $-67.0K | -- | -- | ||
| NET INCOME | |||||||
| Net Income | $-26.3M | $-55.3M | $-69.1M | $-86.5M | $-119.9M | ||
| Net Income (Continuing Operations) | $-26.3M | $-55.3M | $-69.1M | $-86.5M | $-119.9M | ||
| Net Income (Discontinued Operations) | $-26.3M | $-55.3M | $-69.1M | $-86.5M | $-119.9M | ||
| Net Income (Common Stockholders) | $-26.3M | $-55.3M | $-69.1M | $-86.5M | $-119.9M | ||
| TOTALS | |||||||
| Total Expenses | $-26.3M | $58.9M | $79.9M | $104.2M | $132.8M | ||
| SHARE & EPS DATA | |||||||
| Average Shares Outstanding | $13.8M | $41.9M | $42.7M | $57.2M | $59.6M | ||
| Average Shares Outstanding (Diluted) | $13.8M | $41.9M | $42.7M | $57.2M | $59.6M | ||
| Shares Outstanding | $41.6M | $42.4M | $52.5M | $53.1M | $53.9M | ||
| Basic EPS | -- | $-1.32 | $-1.62 | $-1.51 | $-2.01 | ||
| Basic EPS (Continuing Operations) | -- | $-1.32 | $-1.62 | $-1.51 | $-2.01 | ||
| Diluted EPS | $-1.91 | $-1.32 | $-1.62 | $-1.51 | $-2.01 | ||
| Diluted EPS (Continuing Operations) | -- | $-1.32 | $-1.62 | $-1.51 | $-2.01 | ||
| OTHER METRICS | |||||||
| Other Gand A | $5.7M | $15.9M | $17.4M | $24.1M | $29.8M | ||
| Rent And Landing Fees | $5.7M | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TYRA | $33.59 | +3.4% | 564.64K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |